Litigation Details for ASTRAZENECA AB v. ANDRX LABS, LLC (D.N.J. 2014)
✉ Email this page to a colleague
ASTRAZENECA AB v. ANDRX LABS, LLC (D.N.J. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-12-23 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-03-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | Referred To | Tonianne J. Bongiovanni | |
| Patents | 6,143,771; 6,369,085; 6,875,872; 7,411,070; 7,745,466; 8,466,175 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA AB v. ANDRX LABS, LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for ASTRAZENECA AB v. ANDRX LABS, LLC (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-01-10 | 107 | and 6,143,771 (the “‘771 Patent”). (See dkt. 105.) The ‘504 Patent claimed pharmaceutical formulations…its patents-in-suit the ‘504 Patent, the ‘085 Patent, and another patent in the ‘504 Patent Family…obvious-type double patenting in view of the ‘424 patent, the ‘974 Patent, and U.S. Patent No. 5,714,504 ….e., the ‘974 Patent, the ‘818 Patent, WO 95/01977, the ‘960 Patent, the ‘424 Patent, Evans, and Japanese…expired patents: U.S. Patent Nos. 5,877,192 (the “‘192 Patent”), 6,875,872 (the “‘872 Patent”)84, and | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
